Many reports document the ability of certain Rhizobium strains to occupy nodules to the exclusion of other strains. The molecular basis of the superior nodulation competitiveness of any strain is not known, although important advances in recent years have been made (7-9, 12, 19, 20 (12,15,16,22,23,25,26).Hodgson et al. (12) have suggested that bacteriocin production by R. leguminosarum bv. trifolii CB782 is involved in its superior nodulation competitiveness. This was shown by co-inoculating CB782 with bacteriocin-sensitive and -resistant strains. However, these sensitive and resistant strains may differ in other respects that affect nodulation competitiveness aside from bacteriocin production. Transposon mutants of CB782 lacking bacteriocin production would demonstrate the role ofbacteriocin production in competitiveness, since Tn5 is a single point mutagen (3). We are studying the basis of the competitiveness expressed by R. leguminosarum bv. trifolii strain T24, which was isolated in Florida from the nodules of Trifolium dubium in 1937 (17, 25).In 1968, Schwinghamer and Belkengren (25) reported that T24 had three important properties: (a) it induces ineffective nodules on clover roots, (b) it produces a very potent antibiotic inhibitory toward strains of Rhizobium, and (c) it prevents nodulatiop by other strains of R. keguminosarum bv. trifolii. Schwinghamer and Belkengren (25) suggested that the basis for the nodulation competitiveness of T24 was its ability to produce an anti-rhizobial compound.The purpose of the experiments described here are to (a) determine using transposon mutagenesis the roles of antibiotic production and nodulation in the expression of nodulation competitiveness by T24, (b) determine the range of anti-rhizobial activity of the T24 antibiotic, and (c) determine whether T24 can induce effective nodules on any available clover species.